Lashkov Alexander A, Zhukhlistova Nadezhda E, Gabdoulkhakov Azat H, Shtil Alexander A, Efremov Roman G, Betzel Christian, Mikhailov Al'bert M
A. V. Shubnikov Institute of Crystallography, Russian Academy of Sciences, 59 Leninsky Prospect, 119333 Moscow, Russia.
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):51-60. doi: 10.1107/S0907444909044175. Epub 2009 Dec 21.
Uridine nucleoside phosphorylase is an important drug target for the development of anti-infective and antitumour agents. The X-ray crystal structure of Salmonella typhimurium uridine nucleoside phosphorylase (StUPh) complexed with its inhibitor 2,2'-anhydrouridine, phosphate and potassium ions has been solved and refined at 1.86 A resolution (R(cryst) = 17.6%, R(free) = 20.6%). The complex of human uridine phosphorylase I (HUPhI) with 2,2'-anhydrouridine was modelled using a computational approach. The model allowed the identification of atomic groups in 2,2'-anhydrouridine that might improve the interaction of future inhibitors with StUPh and HUPhI.
尿苷核苷磷酸化酶是开发抗感染和抗肿瘤药物的重要药物靶点。鼠伤寒沙门氏菌尿苷核苷磷酸化酶(StUPh)与其抑制剂2,2'-脱水尿苷、磷酸和钾离子形成的复合物的X射线晶体结构已在1.86 Å分辨率下解析并精修(R(cryst)=17.6%,R(free)=20.6%)。利用计算方法对人尿苷磷酸化酶I(HUPhI)与2,2'-脱水尿苷的复合物进行了建模。该模型有助于识别2,2'-脱水尿苷中的原子基团,这些基团可能会增强未来抑制剂与StUPh和HUPhI的相互作用。